Larger than life: Mitochondria and the Bcl-2 family

Leukemia Research

Volumn 31, Issue 3, 2007, Pages 277-286

  Skommer, Joanna ^a   Wlodkowic, Donald ^a   Deptala, Andrzej ^b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Apoptosis; Bcl 2; Cancer; Cell death; Mitochondria

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CYTOCHROME C; FK 506 BINDING PROTEIN; KU ANTIGEN; MESSENGER RNA; OBLIMERSEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; CANCER CELL; CELL DEATH; CELL FATE; CELL KILLING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME RELEASE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HYPERPOLARIZATION; LASER SCANNING CYTOMETRY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NONHODGKIN LYMPHOMA; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; STRUCTURAL HOMOLOGY;

ANIMALS; CELL DEATH; HUMANS; MITOCHONDRIA; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33846106906     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.027     Document Type: Review

References (130)

1. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2 (2001) 589-598
2. Nelson D.A., and White E. Exploiting different ways to die. Genes Dev 18 (2004) 1223-1226
3. Armstrong J.S. Mitochondria: a target for cancer therapy. Br J Pharmacol 147 (2006) 239-248
4. Bouchier-Hayes L., Lartigue L., and Newmeyer D.D. Mitochondria: pharmacological manipulation of cell death. J Clin Invest 115 (2005) 2640-2647
5. Dias N., and Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70 (2005) 1-12
6. Shore G.C., and Viallet J. Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer. Hematology (Am Soc Hematol Educ Program) (2005) 226-230
7. Gardner C.R. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism. Expert Rev Anticancer Ther 4 (2004) 1157-1177
8. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310 (2005) 66-67
9. Kim R., Emi M., and Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57 (2005) 545-553
10. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112 (2003) 481-490
11. Schmidt-Mende J., Gogvadze V., Hellstrom-Lindberg E., and Zhivotovsky B. Early mitochondrial alterations in ATRA-induced cell death. Cell Death Differ 13 (2006) 119-128
12. Wlodkowic D., Skommer J., and Pelkonen J. Multiparametric analysis of HA14-1-induced apoptosis in follicular lymphoma cells. Leuk Res 30 (2006) 1187-1192
13. Deptala A., Bedner E., and Darzynkiewicz Z. Unique analytical capabilities of laser scanning cytometry (LSC) that complement flow cytometry. Folia Histochem Cytobiol 39 (2001) 87-89
14. Lakhani S.A., Masud A., Kuida K., Porter Jr. G.A., Booth C.J., Mehal W.Z., et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311 (2006) 847-851
15. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
16. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blalchy-Dyson E., Di Lisa F., et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273 (2006) 2077-2099
17. He L., and Lemasters J.J. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?. FEBS Lett 512 (2002) 1-7
18. Beutner G., Ruck A., Riede B., and Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1368 (1998) 7-18
19. Zhu Y., Xu H., and Huang K. Mitochondrial permeability transition and cytochrome c release induced by selenite. J Inorg Biochem 90 (2002) 43-50
20. Goldstein J.C., Munoz-Pinedo C., Ricci J.E., Adams S.R., Kelekar A., Schuler M., et al. Cytochrome c is released in a single step during apoptosis. Cell Death Differ 12 (2005) 453-462
21. Martinez-Caballero S., Dejean L.M., Jonas E.A., and Kinnally K.W. The role of the mitochondrial apoptosis induced channel MAC in cytochrome c release. J Bioenerg Biomembr 37 (2005) 155-164
22. Bossy-Wetzel E., Newmeyer D.D., and Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarisation. EMBO J 17 (1998) 37-49
23. Waterhouse N.J., Ricci J.E., and Green D.R. And all of a sudden it's over: mitochondrial outer-membrane permeabilization in apoptosis. Biochimie 84 (2002) 113-121
24. Ricci J.E., Gottlieb R.A., and Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 160 (2003) 65-75
25. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
26. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-658
27. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 159 (2002) 931-938
28. Lee Y.J., Jeong S.Y., Karbowski M., Smith C.L., and Youle R.J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15 (2004) 5001-5011
29. Chipuk J.E., Bouchier-Hayes L., and Green D.R. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13 (2006) 1396-1402
30. De Giorgi F., Lartigue L., Bauer M.K., Schubert A., Grimm S., Hanson G.T., et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 16 (2002) 607-609
31. Precht T.A., Phelps R.A., Linseman D.A., Butts B.D., Le S.S., Laessig T.A., et al. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ 12 (2005) 255-265
32. Siskind L.J., Kolesnick R.N., and Colombini M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem 277 (2002) 26796-26803
33. Siskind L.J., Fluss S., Bui M., and Colombini M. Sphingosine forms channels in membranes that differ greatly from those formed by ceramide. J Bioenerg Biomembr 37 (2005) 227-236
34. Ricci J.E., Waterhouse N., and Green D.R. Mitochondrial functions during cell death, a complex (I-V) dilemma. Cell Death Differ 10 (2003) 488-492
35. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
36. Arnoult D., Gaume B., Karbowski M., Sharpe J.C., Cecconi F., and Youle R.J. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 22 (2003) 4385-4399
37. Otera H., Ohsakaya S., Nagaura Z., Ishihara N., and Mihara K. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J 24 (2005) 1375-1386
38. Uren R.T., Dewson G., Bonzon C., Lithgow T., Newmeyer D.D., and Kluck R.M. Mitochondrial release of pro-apoptotic proteins: electrostatic interactions can hold cytochrome c but not Smac/DIABLO to mitochondrial membranes. J Biol Chem 280 (2005) 2266-2274
39. Kagan V.E., Tyurin V.A., Jiang J., Tyurina Y.Y., Ritov V.B., Amoscato A.A., et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1 (2005) 223-232
40. Kalinowska M., Garncarz W., Pietrowska M., Garrard W.T., and Widlak P. Regulation of the human apoptotic DNase/RNase endonuclease G: involvement of Hsp70 and ATP. Apoptosis 10 (2005) 821-830
41. Sekine K., Hao Y., Suzuki Y., Takahashi R., Tsuruo T., and Naito M. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem Biophys Res Commun 330 (2005) 279-285
42. Ekert P.G., and Vaux D.L. The mitochondrial death squad: hardened killers or innocent bystanders?. Curr Opin Cell Biol 17 (2005) 626-630
43. van Loo G., Saelens X., van Gurp M., MacFarlane M., Martin S.J., and Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9 (2002) 1031-1042
44. Hail Jr. N., Carter B.Z., Konopleva M., and Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11 (2006) 889-904
45. Fleischer A., Rebollo A., and Ayllon V. BH3-only proteins: the lords of death. Arch Immunol Ther Exp (Warsz) 51 (2003) 9-17
46. Gelinas C., and White E. BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev 19 (2005) 1263-1268
47. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
48. Packham G., and Stevenson F.K. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology 114 (2005) 441-449
49. Willis S.N., and Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17 (2005) 617-625
50. Kataoka T., Holler N., Micheau O., Martinon F., Tinel A., Hofmann K., et al. a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J Biol Chem 276 (2001) 19548-19554
51. Coultas L., Pellegrini M., Visvader J.E., Lindeman G.J., Chen L., Adams J.M., et al. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death Differ 10 (2003) 185-192
52. Ke N., Godzik A., and Reed J.C. Bcl-B a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J Biol Chem 276 (2001) 12481-12484
53. Guo B., Godzik A., and Reed J.C. Bcl-G a novel pro-apoptotic member of the Bcl-2 family. J Biol Chem 276 (2001) 2780-2785
54. Puthalakath H., and Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9 (2002) 505-512
55. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13 (1999) 1899-1911
56. Mikhailov V., Mikhailova M., Pulkrabek D.J., Dong Z., Venkatachalam M.A., and Saikumar P. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 276 (2001) 18361-18374
57. Mikhailov V., Mikhailova M., Degenhardt K., Venkatachalam M.A., White E., and Saikumar P. Association of Bax and Bak homo-oligomers in mitochondria Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem 278 (2003) 5367-5376
58. Sundararajan R., and White E. E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J Virol 75 (2001) 7506-7516
59. Sundararajan R., Cuconati A., Nelson D., and White E. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J Biol Chem 276 (2001) 45120-45127
60. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17 (2005) 393-403
61. Green D.R. At the gates of death. Cancer Cell 9 (2006) 328-330
62. Certo M., Moore Vdel G., Nishino M., Wei G., Korsmeyer S., Armstrong S.A., et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9 (2006) 351-365
63. Thomenius M.J., and Distelhorst C.W. Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance. J Cell Sci 116 (2003) 4493-4499
64. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
65. Grinberg M., Sarig R., Zaltsman Y., Frumkin D., Grammatikakis N., Reuveny E., et al. tBID homooligomerizes in the mitochondrial membrane to induce apoptosis. J Biol Chem 77 (2002) 12237-12245
66. Sharpe J.C., Arnoult D., and Youle R.J. Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 1644 (2004) 107-113
67. Gonzalvez F., Pariselli F., Dupaigne P., Budihardjo I., Lutter M., Antonsson B., et al. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ 12 (2005) 614-626
68. Tan K.O., Fu N.Y., Sukumaran S.K., Chan S.L., Kang J.H., Poon K.L., et al. MAP-1 is a mitochondrial effector of Bax. Proc Natl Acad Sci USA 102 (2005) 14623-14628
69. Mei Y., Du W., Yang Y., and Wu M. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene 24 (2005) 7224-7237
70. Chandra D., Choy G., Daniel P.T., and Tang D.G. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J Biol Chem 280 (2005) 19051-19061
71. Yee K.S., and Vousden K.H. Complicating the complexity of p53. Carcinogenesis 26 (2005) 1317-1322
72. Schuler M., and Green D.R. Transcription, apoptosis and p53: catch-22. Trends Genet 21 (2005) 182-187
73. Tomita Y., Marchenko N., Erster S., Nemajerova A., Dehner A., Klein C., et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281 (2006) 8600-8606
74. Sawada M., Sun W., Hayes P., Leskov K., Boothman D.A., and Matsuyama S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5 (2003) 320-329
75. Nothwehr S.F., and Martinou J.C. A retention factor keeps death at bay. Nat Cell Biol 5 (2003) 281-283
76. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (2004) 527-540
77. Gillespie D.A., and Vousden K.H. The secret life of histones. Cell 114 (2003) 655-656
78. Pastorino J.G., Shulga N., and Hoek J.B. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277 (2002) 7610-7618
79. Jin S., Zhuo Y., Guo W., and Field J. p21-activated kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. J Biol Chem 280 (2005) 24698-24705
80. Takahashi Y., Karbowski M., Yamaguchi H., Kazi A., Wu J., Sebti S.M., et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol 25 (2005) 9369-9382
81. Matsuda K., Yoshida K., Taya Y., Nakamura K., Nakamura Y., and Arakawa H. p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 62 (2002) 2883-2889
82. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381 (1996) 335-341
83. Schendel S.L., Montal M., and Reed J.C. Bcl-2 family proteins as ion-channels. Cell Death Differ 5 (1998) 372-380
84. Garcia-Saez A.J., Coraiola M., Dalla Serra M., Mingarro I., Menestrina G., and Salgado J. Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins. Biophys J 88 (2005) 3976-3990
85. Lindsten T., and Thompson C.B. Cell death in the absence of Bax and Bak. Cell Death Differ 13 (2006) 1272-1276
86. Kim M., Jung S.O., Park K., Jeong E.J., Joung H.A., Kim T.H., et al. Detection of Bax protein conformational change using a surface plasmon resonance imaging-based antibody chip. Biochem Biophys Res Commun 338 (2005) 1834-1838
87. Hetz C., Vitte P.A., Bombrun A., Rostovtseva T.K., Montessuit S., Hiver A., et al. Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia. J Biol Chem 280 52 (2005) 42960-42970
88. Dejean L.M., Martinez-Caballero S., Guo L., Hughes C., Teijido O., Ducret T., et al. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol Biol Cell 16 (2005) 2424-2432
89. Pavlov E.V., Priault M., Pietkiewicz D., Cheng E.H., Antonsson B., Manon S., et al. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 155 (2001) 725-731
90. Dejean L.M., Martinez-Caballero S., and Kinnally K.W. Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis?. Cell Death Differ 13 (2006) 1387-1395
91. Cheng E.H., Sheiko T.V., Fisher J.K., Craigen W.J., and Korsmeyer S.J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301 (2003) 513-517
92. Bernardi P., Petronilli V., Di Lisa F., and Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 26 (2001) 112-117
93. Vander Heiden M.G., and Thompson C.B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?. Nat Cell Biol 1 (1999) E209-E216
94. Gong X.M., Choi J., Franzin C.M., Zhai D., Reed J.C., and Marassi F.M. Conformation of membrane-associated proapoptotic tBid. J Biol Chem 279 (2004) 28954-28960
95. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002) 331-342
96. Rudner J., Jendrossek V., and Belka C. New insights in the role of Bcl-2 Bcl-2 and the endoplasmic reticulum. Apoptosis 7 (2002) 441-447
97. Thomenius M.J., Wang N.S., Reineks E.Z., Wang Z., and Distelhorst C.W. Bcl-2 on the endoplasmic reticulum regulates Bax activity by binding to BH3-only proteins. J Biol Chem 278 (2003) 6243-6250
98. 2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem 280 (2005) 23829-23836
99. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005) 927-939
100. Pattingre S., and Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res 66 (2006) 2885-2888
101. Kanzawa T., Zhang L., Xiao L., Germano I.M., Kondo Y., and Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24 (2005) 980-991
102. Daido S., Kanzawa T., Yamamoto A., Takeuchi H., Kondo Y., and Kondo S. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64 (2004) 4286-4293
103. Hetz C., Bernasconi P., Fisher J., Lee A.H., Bassik M.C., Antonsson B., et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312 (2006) 572-576
104. 2+: a control point for apoptosis. Science 300 (2003) 135-139
105. Kamer I., Sarig R., Zaltsman Y., Niv H., Oberkovitz G., Regev L., et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122 (2005) 593-603
106. Zinkel S.S., Hurov K.E., Ong C., Abtahi F.M., Gross A., and Korsmeyer S.J. A role for proapoptotic BID in the DNA-damage response. Cell 122 (2005) 579-591
107. Ruiz-Vela A., Albar J.P., and Martinez C.A. Apaf-1 localization is modulated indirectly by Bcl-2 expression. FEBS Lett 501 (2001) 79-83
108. Hausmann G., O'Reilly L.A., van Driel R., Beaumont J.G., Strasser A., Adams J.M., et al. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol 149 (2000) 623-634
109. Huang D.C., O'Reilly L.A., Strasser A., and Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16 (1997) 4628-4638
110. Janumyan Y.M., Sansam C.G., Chattopadhyay A., Cheng N., Soucie E.L., Penn L.Z., et al. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J 22 (2003) 5459-5470
111. Jamil S., Sobouti R., Hojabrpour P., Raj M., Kast J., and Duronio V. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem J 387 (2005) 659-667
112. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442
113. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger U., McKearn J.P., et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57 (1989) 79-88
114. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
115. Brown J.M., and Attardi L.D. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5 (2005) 231-237
116. Rassidakis G.Z., Jones D., Lai R., Ramalingam P., Sarris A.H., McDonnell T.J., et al. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol 200 (2003) 240-248
117. Rassidakis G.Z., Medeiros L.J., Vassilakopoulos T.P., Viviani S., Bonfante V., Nadali G., et al. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood 100 (2002) 3935-3941
118. Stahnke K., Mohr A., Liu J., Meyer L.H., Karawajew L., and Debatin K.M. Identification of deficient mitochondrial signaling in apoptosis resistant leukemia cells by flow cytometric analysis of intracellular cytochrome c, caspase-3 and apoptosis. Apoptosis 9 (2004) 457-465
119. Hemann M.T., Bric A., Teruya-Feldstein J., Herbst A., Nilsson J.A., Cordon-Cardo C., et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436 (2005) 807-811
120. Skommer J., Wlodkowic D., Matto M., Eray M., and Pelkonen J. HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells. Leuk Res 30 (2006) 322-331
121. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
122. Subramanian C., Opipari Jr. A.W., Bian X., Castle V.P., and Kwok R.P. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 102 (2005) 4842-4847
123. Shirane M., and Nakayama K.I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5 (2003) 28-37
124. Lowe S.L., Rubinchik S., Honda T., McDonnell T.J., Dong J.Y., and Norris J.S. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Gene Ther 8 (2001) 1363-1371
125. Naumann U., Schmidt F., Wick W., Frank B., Weit S., Gillissen B., et al. Adenoviral natural born killer gene therapy for malignant glioma. Hum Gene Ther 14 (2003) 1235-1246
126. Shinoura N., and Hamada H. Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Curr Gene Ther 3 (2003) 147-153
127. Toyota H., Kondo S., Kyo S., and Mizuguchi J. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Anticancer Res 26 (2006) 99-105
128. Gao G., and Dou Q.P. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem 80 (2000) 53-72
129. Wood D.E., and Newcomb E.W. Cleavage of Bax enhances its cell death function. Exp Cell Res 256 (2000) 375-382
130. Jiang X., Kim H.E., Shu H., Zhao Y., Zhang H., Kofron J., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299 (2003) 223-226